Cryptococcus neoformans: Latency and Disease

Françoise Dromer; Arturo Casadevall; John Perfect; Tania Sorrell

doi:10.1128/9781555816858.ch31

Chapter 31 : Cryptococcus neoformans: Latency and Disease

Authors: Françoise Dromer¹, Arturo Casadevall², John Perfect³, Tania Sorrell⁴

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Institut Pasteur, Molecular Mycology Unit, CNRS URA3012, 75724 Paris cedex 15, France; 2: Department of Microbiology & Immunology, Albert Einstein College of Medicine, Jack and Pearl Resnick Campus, Bronx, NY 10461; 3: Department of Medicine, Division of Infectious Diseases, Duke University Mycology Research Unit (DUMRU), Durham, NC 27710; 4: Centre for Infectious Diseases and Microbiology & Westmead Millennium Institute, Western Clinical School, University of Sydney, Wentworthville NSW 2145, Australia

Content Type: Monograph

Publication Year: 2011

Category: Clinical Microbiology; Fungi and Fungal Pathogenesis

Book DOI: 10.1128/9781555816858

Chapter DOI: 10.1128/9781555816858.ch31

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Cryptococcus neoformans: Latency and Disease, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555816858/9781555815011_Chap31-1.gif /docserver/preview/fulltext/10.1128/9781555816858/9781555815011_Chap31-2.gif

Abstract:

This chapter reviews the evidence of disease after acute infection and reactivation of latent infection, considering the newer epidemiological and serological studies and the older anatomical evidence. Cryptococcal meningitis was diagnosed in an HIV-infected patient who helped dismantle an aviary, and another patient had pigeons nesting in the ceiling above his desk. Cryptococcal infection occurs in children as demonstrated by the existence of antibodies to Cryptococcus neoformans in children. Primary pulmonary cryptococcosis may be asymptomatic or confused with viral infections frequently observed during childhood. The high incidence of disease reported in the Vancouver Island outbreak may not be the norm, even though it appears from epidemiological studies that C. neoformans has a greater potential for reactivation of infection leading to disease than C. gattii. The overwhelming majority of individuals with persistent/latent infection would remain asymptomatic as long as they retained an intact immune system. In murine inhalational models acute pulmonary infection with C. neoformans is rapidly followed by the appearance of cryptococci both free and within macrophages in the lymphoid sinuses of hilar (draining) lymph nodes. The best animal model available for the study of latency and reactivation is experimental rat pulmonary cryptococcosis.

Citation: Dromer F, Casadevall A, Perfect J, Sorrell T. 2011. Cryptococcus neoformans: Latency and Disease, p 431-439. In Heitman J, Kozel T, Kwon-Chung K, Perfect J, Casadevall A (ed), Cryptococcus. ASM Press, Washington, DC. doi: 10.1128/9781555816858.ch31

Key Concept Ranking

Restriction Fragment Length Polymorphism: 0.43301028

0.43301028

Highlighted Text: Show | Hide

Full text loading...

References

/content/book/10.1128/9781555816858.ch31

1. Aberg, J. A.,, L. M. Mundy, and, W. G. Powderly. 1999. Pulmonary cryptococcosis in patients without HIV infection. Chest 115: 734– 740.

2. Almeida,, A. M.,, M. T. Matsumoto,, L. C. Baeza,, E. S. R. B. de Oliveira,, A. A. Kleiner,, S. Melhem Mde, and, M. J. Mendes Giannini. 2007. Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil. FEMS Yeast Res. 7: 152– 164.

3. Alvarez, M., and, A. Casadevall. 2007. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol. 8: 16.

4. Arend,, S. M.,, E. J. Kuijper,, C. F. Allaart,, W. H. Muller, and, J. T. Van Dissel. 2004. Cavitating pneumonia after treatment with infliximab and prednisone. Eur. J. Clin. Microbiol. Infect. Dis. 23: 638– 641.

5. Arora, S., and, G. B. Huffnagle. 2005. Immune regulation during allergic bronchopulmonary mycosis: lessons taught by two fungi. Immunol. Res. 33: 53– 68.

6. Atkinson, A. J., Jr., and, J. E. Bennett. 1968. Experience with a new skin test antigen prepared from Cryptococcus neoformans. Am. Rev. Respir. Dis. 97: 637– 643.

7. Baker, R. D. 1976. The primary pulmonary lymph node complex of cryptococcosis. Am. J. Clin. Pathol. 65: 83– 92.

8. Baker, R. D. 1952. Resectable mycotic lesions and acutely fatal mycoses. JAMA 150: 1579– 1581.

9. Baker, R. D., and, R. K. Haugen. 1955. Tissue changes and tissue diagnosis in cryptococcosis; a study of 26 cases. Am. J. Clin. Pathol. 25: 14– 24.

10. Barchiesi,, F.,, R. J. Hollis,, S. A. Messer,, G. Scalise, M. G. Rinaldi, and, M. A. Pfaller. 1995. Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients. Diagn. Microbiol. Infect. Dis. 23: 99– 103.

11. Blasi,, E.,, A. Brozzetti,, D. Francisci,, R. Neglia,, G. Cardinali,, F. Bistoni,, V. Vidotto, and, F. Baldelli. 2001. Evidence of microevolution in a clinical case of recurrent Cryptococcus neoformans meningoencephalitis. Eur. J. Clin. Microbiol. Infect. Dis. 20: 535– 543.

12. Brandt,, M. E.,, L. C. Hutwagner,, L. A. Klug,, W. S. Baughman,, D. Rimland,, E. A. Graviss,, R. J. Hamill,, C. Thomas,, P. G. Pappas,, A. L. Reingold, and, R. W. Pinner. 1996. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group. J. Clin. Microbiol. 34: 912– 917.

13. Casadevall, A., and, J. R. Perfect. 1998. Cryptococcus neoformans. ASM Press, Washington, DC.

14. Chen,, L. C.,, D. L. Goldman,, T. L. Doering,, L. Pirofski, and, A. Casadevall. 1999. Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infect. Immun. 67: 2218– 2224.

15. Chen,, S.,, T. Sorrell,, G. Nimmo,, B. Speed,, B. Currie,, D. Ellis,, D. Marriott,, T. Pfeiffer,, D. Parr, and, K. Byth. 2000. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin. Infect. Dis. 31: 499– 508.

16. Christianson, J. C.,, W. Engber, and, D. Andes. 2003. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med. Mycol. 41: 177– 188.

17. Currie, B. P.,, L. F. Freundlich, and, A. Casadevall. 1994. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J. Clin. Microbiol. 32: 1188– 1192.

18. Davis,, J.,, W. Y. Zheng,, A. Glatman-Freedman,, J. A. Ng,, M. R. Pagcatipunan,, H. Lessin,, A. Casadevall, and, D. L. Goldman. 2007. Serologic evidence for regional differences in pediatric cryptococcal infection. Pediatr. Infect. Dis. J. 26: 549– 551.

19. DeShaw, M., and, L. A. Pirofski. 1995. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals. Clin. Exp. Immunol. 99: 425– 432.

20. Desnos-Ollivier, M.,, S. Patel,, A. R. Spaulding,, C. Charlier,, D. Garcia-Hermoso,, K. Nielsen, and, F. Dromer. 2010. Mixed infections and in vivo evolution in the human fungal pathogen Cryptococcus neoformans. mBio 1: e00091-10.doi:10.1128/mBio.00091– 10.

21. Dev, D.,, G. S. Basran,, D. Slater,, P. Taylor, and, M. Wood. 1994. Immunodeficiency without HIV. Consider HIV negative immunodeficiency in cryptococcosis. BMJ 308: 1436.

22. Dhasmana,, D. J.,, K. Dheda,, P. Ravn,, R. J. Wilkinson, and, G. Meintjes. 2008. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs 68: 191– 208.

23. Diamond, R. D., and, J. E. Bennett. 1974. Prognostic factors in cryptococcal meningitis. A study in 111 cases. Ann. Intern. Med. 80: 176– 181.

24. Dominiak, A.,, B. Interewicz,, E. Swoboda, and, W. L. Ol-szewski. 2006. Endogeneous sources of infection in transplant recipients. Ann. Transplant. 11: 30– 37.

25. Dromer,, F.,, P. Aucouturier,, J. P. Clauvel,, G. Saimot, and, P. Yeni. 1988. Cryptococcus neoformans antibody levels in patients with AIDS. Scand. J. Infect. Dis. 20: 283– 285.

26. Dromer, F.,, S. Mathoulin,, B. Dupont, and, A. Laporte. 1996. Epidemiology of cryptococcosis in France: a 9-year survey (1985–1993). French Cryptococcosis Study Group. Clin. Infect. Dis. 23: 82– 90.

27. Dromer, F.,, O. Ronin, and, B. Dupont. 1992. Isolation of Cryptococcus neoformans var. gattii from an Asian patient in France: evidence for dormant infection in healthy subjects. J. Med. Vet. Mycol. 30: 395– 397.

28. Duperval, R.,, P. E. Hermans,, N. S. Brewer, and, G. D. Roberts. 1977. Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract. Chest 72: 13– 19.

29. Ellis, D. H., and, T. Pfeiffer. 1994. Cryptococcosis and the ecology of Cryptococcus neoformans. Jpn. J. Med. Mycol. 35: 111– 122.

30. Ellis, D. H., and, T. J. Pfeiffer. 1990. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 336: 923– 925.

31. Ellis, D. H., and, T. J. Pfeiffer. 1990. Natural habitat of Cryptococcus neoformans var. gattii. J. Clin. Microbiol. 28: 1642– 1644.

32. Emmons, C. W. 1951. Isolation of Cryptococcus neoformans from soil. J. Bacteriol. 62: 685– 690.

33. Feldmesser, M.,, C. Harris,, S. Reichberg,, S. Khan, and, A. Casadevall. 1996. Serum cryptococcal antigen in patients with AIDS. Clin. Infect. Dis. 23: 827– 830.

34. Feldmesser, M.,, Y. Kress,, P. Novikoff, and, A. Casadevall. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68: 4225– 4237.

35. Fessel, W. J. 1993. Cryptococcal meningitis after unusual exposures to birds. N. Engl. J. Med. 328: 1354– 1355.

36. Fink, J. N.,, J. J. Barboriak, and, L. Kaufman. 1968. Cryptococcal antibodies in pigeon breeders’ disease. J. Allergy 41: 297– 301.

37. Franzot,, S. P.,, J. S. Hamdan,, B. P. Currie, and, A. Casadevall. 1997. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J. Clin. Microbiol. 35: 2243– 2251.

38. Fraser,, J. A.,, S. S. Giles,, E. C. Wenink,, S. G. Geunes-Boyer,, J. R. Wright,, S. Diezmann,, A. Allen,, J. E. Stajich,, F. S. Dietrich,, J. R. Perfect, and, J. Heitman. 2005. Samesex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437: 1360– 1364.

39. Gadebusch, H. H., and, P. W. Gikas. 1965. The effect of cortisone upon experimental pulmonary cryptococcosis. Am. Rev. Respir. Dis. 92: 64– 74.

40. Garcia-Hermoso, D.,, F. Dromer, and, G. Janbon. 2004. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect. Immun. 72: 3359– 3365.

41. Garcia-Hermoso, D.,, G. Janbon, and, F. Dromer. 1999. Epidemiological evidence for dormant Cryptococcus neoformans infection. J. Clin. Microbiol. 37: 3204– 3209.

42. Garcia-Hermoso,, D.,, S. Mathoulin-Pelissier,, B. Couprie,, O. Ronin,, B. Dupont, and, F. Dromer. 1997. DNA typing suggests pigeon droppings as a source of pathogenic Cryptococcus neoformans serotype D. J. Clin. Microbiol. 35: 2683– 2685.

43. Goldman, D.,, S. C. Lee, and, A. Casadevall. 1994. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect. Immun. 62: 4755– 4761.

44. Goldman,, D. L.,, J. Davis,, F. Bommarito,, X. Shao, and, A. Casadevall. 2006. Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma. J. Infect. Dis. 193: 1178– 1186.

45. Goldman,, D. L.,, H. Khine,, J. Abadi,, D. J. Lindenberg,, L. Pirofski,, R. Niang, and, A. Casadevall. 2001. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107: e66.

46. Goldman,, D. L.,, S. C. Lee,, A. J. Mednick,, L. Montella, and, A. Casadevall. 2000. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect. Immun. 68: 832– 838.

47. Hage,, C. A.,, K. L. Wood,, H. T. Winer-Muram,, S. J. Wilson,, G. Sarosi, and, K. S. Knox. 2003. Pulmonary cryptococcosis after initiation of antitumor necrosis factoralpha therapy. Chest 124: 2395– 2397.

48. Hamilton, C. D. 2005. Immunosuppression related to collagen-vascular disease or its treatment. Proc. Am. Thorac. Soc. 2: 456– 460.

49. Haugen, R. K., and, R. D. Baker. 1954. The pulmonary lesions in cryptococcosis with special reference to subpleural nodules. Am. J. Clin. Pathol. 24: 1381– 1390.

50. Haynes,, K. A.,, D. J. Sullivan,, D. C. Coleman,, J. C. Clarke,, R. Emilianus,, C. Atkinson, and, K. J. Cann. 1995. Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting. J. Clin. Microbiol. 33: 99– 102.

51. Henderson, D. K.,, J. E. Bennett, and, M. A. Huber. 1982. Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. J. Clin. Invest. 69: 1185– 1190.

52. Hiremath,, S. S.,, A. Chowdhary,, T. Kowshik,, H. S. Randhawa,, S. Sun, and, J. Xu. 2008. Long-distance dispersal and recombination in environmental populations of Cryptococcus neoformans var. grubii from India. Microbiology 154: 1513– 1524.

53. Horcajada,, J. P.,, J. L. Pena,, V. M. Martinez-Taboada,, T. Pina,, I. Belaustegui,, M. E. Cano,, D. Garcia-Palomo, and, M. C. Farinas. 2007. Invasive cryptococcosis and adalimumab treatment. Emerg. Infect. Dis. 13: 953– 955.

54. Igreja,, R. P.,, M. S. Lazéra,, B. Wanke, M. C. Galhardo,, S. E. Kidd, and, W. Meyer. 2004. Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Med. Mycol. 42: 229– 238.

55. Ingram,, C. W.,, H. B. Haywood,, 3rd, V. M. Morris,, R. L. Allen, and, J. R. Perfect. 1993. Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated cases. Infect. Control Hosp. Epidemiol. 14: 719– 722.

56. Jain,, N.,, B. L. Wickes,, S. M. Keller,, J. Fu,, A. Casadevall,, P. Jain,, M. A. Ragan,, U. Banerjee, and, B. C. Fries. 2005. Molecular epidemiology of clinical Cryptococcus neoformans strains from India. J. Clin. Microbiol. 43: 5733– 5742.

57. Kluger,, E. K.,, H. K. Karaoglu,, M. B. Krockenberger,, P. K. Della Torre,, W. Meyer, and, R. Malik. 2006. Recrudescent cryptococcosis, caused by Cryptococcus gattii (molecular type VGII), over a 13-year period in a Birman cat. Med. Mycol. 44: 561– 566.

58. Kozic, H.,, K. Riggs,, F. Ringpfeil, and, J. B. Lee. 2008. Disseminated Cryptococcus neoformans after treatment with infliximab for rheumatoid arthritis. J. Am. Acad. Dermatol. 58: S95– 96.

59. Krajden,, S.,, R. C. Summerbell,, J. Kane, I. F. Salkin,, M. E. Kemna,, M. G. Rinaldi,, M. Fuksa,, E. Spratt,, C. Rodrigues, and, J. Choe. 1991. Normally saprobic cryptococci isolated from Cryptococcus neoformans infections. J. Clin. Microbiol. 29: 1883– 1887.

60. Krockenberger,, M. B.,, P. J. Canfield,, J. Barnes,, L. Vogelnest,, J. Connolly,, C. Ley, and, R. Malik. 2002. Cryptococcus neoformans var. gattii in the koala ( Phascolarctos cinereus): serological evidence for subclinical cryptococcosis. Med. Mycol. 40: 273– 282.

61. Larsen,, R. A.,, S. Bozzette, J. A. McCutchan,, J. Chiu, M. A. Leal, and, D. D. Richman. 1989. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. California Collaborative Treatment Group. Ann. Intern. Med. 111: 125– 128.

62. Lester,, S. J.,, N. J. Kowalewich,, K. H. Bartlett,, M. B. Krockenberger,, T. M. Fairfax, and, R. Malik. 2004. Clinicopathologic features of an unusual outbreak of cryptococcosis in dogs, cats, ferrets, and a bird: 38 cases (January to July 2003). J. Am. Vet. Med. Assoc. 225: 1716– 1722.

63. Liechty,, C. A.,, P. Solberg,, W. Were,, J. P. Ekwaru,, R. L. Ransom,, P. J. Weidle,, R. Downing,, A. Coutinho, and, J. Mermin. 2007. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop. Med. Int. Health 12: 929– 935.

64. Lindberg, J.,, F. Hagen,, A. Laursen,, J. Stenderup, and, T. Boekhout. 2007. Cryptococcus gattii risk for tourists visiting Vancouver Island, Canada. Emerg. Infect. Dis. 13: 178– 179.

65. Littman, M. L., and, S. S. Schneierson. 1959. Cryptococcus neoformans in pigeon excreta in New York City. Am. J. Hyg. 69: 49– 59.

66. Litvintseva, A. P.,, L. Kestenbaum,, R. Vilgalys, and, T. G. Mitchell. 2005. Comparative analysis of environmental and clinical populations of Cryptococcus neoformans. J. Clin. Microbiol. 43: 556– 564.

67. Lortholary,, O.,, A. Fontanet,, N. Memain,, A. Martin,, K. Sitbon, and, F. Dromer. 2005. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19: 1043– 1049.

68. Ma, H.,, J. E. Croudace,, D. A. Lammas, and, R. C. May. 2007. Direct cell-to-cell spread of a pathogenic yeast. BMC Immunol. 8: 15.

69. MacDougall, L., and, M. Fyfe. 2006. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J. Clin. Microbiol. 44: 1851– 1852.

70. Magee, J. T.,, C. Philpot,, J. Yang, and, I. K. Hosein. 1994. Pyrolysis typing of isolates from a recurrence of systemic cryptococcosis. J. Med. Microbiol. 40: 165– 169.

71. Malik,, R.,, M. B. Krockenberger,, G. Cross,, R. Doneley,, D. N. Madill,, D. Black,, P. McWhirter,, A. Rozenwax,, K. Rose,, M. Alley,, D. Forshaw,, I. Russell-Brown,, A. C. Johnstone,, P. Martin,, C. R. O’Brien, and, D. N. Love. 2003. Avian cryptococcosis. Med. Mycol. 41: 115– 124.

72. Mandal, P.,, U. Banerjee,, A. Casadevall, and, J. D. Nosanchuk. 2005. Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India. J. Clin. Microbiol. 43: 4766– 4772.

73. Martinez, L. R.,, J. Garcia-Rivera, and, A. Casadevall. 2001. Cryptococcus neoformans var. neoformans (serotype D) strains are more susceptible to heat than C. neoformans var. grubii (serotype A) strains. J. Clin. Microbiol. 39: 3365– 3367.

74. Micol,, R.,, O. Lortholary,, B. Sar,, D. Laureillard,, C. Ngeth, J. P. Dousset,, H. Chanroeun,, L. Ferradini,, P. J. Guerin,, F. Dromer, and, A. Fontanet. 2007. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J. Acquir. Immune Defic. Syndr. 45: 555– 559.

75. Miyagawa, T.,, T. Ochi, and, H. Takahashi. 1978. Hypersensitivity pneumonitis with antibodies to Cryptococcus neoformans. Clin. Allergy 8: 501– 509.

76. Morgan,, J.,, K. M. McCarthy,, S. Gould,, K. Fan,, B. Arthington-Skaggs,, N. Iqbal,, K. Stamey,, R. A. Hajjeh,, M. E. Brandt, and Gauteng Cryptococcal Surveillance Initiative. 2006. Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002–2004. Clin. Infect. Dis. 43: 1077– 1080.

77. Munoz,, P.,, M. Giannella,, M. Valerio,, T. Soria,, F. Diaz, J. L. Longo, and, E. Bouza. 2007. Cryptococcal meningitis in a patient treated with infliximab. Diagn. Microbiol. Infect. Dis. 57: 443– 446.

78. Neuville,, S.,, F. Dromer,, O. Morin,, B. Dupont,, O. Ronin, and, O. Lortholary. 2003. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin. Infect. Dis. 36: 337– 347.

79. Newberry,, W. M.,, Jr., J. E. Walter,, J. W. Chandler, Jr., and, F. E. Tosh. 1967. Epidemiologic study of Cryptococcus neoformans. Ann. Intern. Med. 67: 724– 732.

80. Nosanchuk,, J. D.,, S. Shoham, B. C. Fries,, D. S. Shapiro,, S. M. Levitz, and, A. Casadevall. 2000. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann. Intern. Med. 132: 205– 208.

81. Noverr,, M. C.,, G. M. Cox,, J. R. Perfect, and, G. B. Huffnagle. 2003. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect. Immun. 71: 1538– 1547.

82. O’Brien,, C. R.,, M. B. Krockenberger,, D. I. Wigney,, P. Martin, and, R. Malik. 2004. Retrospective study of feline and canine cryptococcosis in Australia from 1981 to 2001: 195 cases. Med. Mycol. 42: 449– 460.

83. Pappas,, P. G.,, J. R. Perfect,, G. A. Cloud,, R. A. Larsen,, G. A. Pankey,, D. J. Lancaster,, H. Henderson,, C. A. Kauffman,, D. W. Haas,, M. Saccente,, R. J. Hamill,, M. S. Holloway,, R. M. Warren, and, W. E. Dismukes. 2001. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin. Infect. Dis. 33: 690– 699.

84. Passoni, L. F.,, B. Wanke,, M. M. Nishikawa, and, M. S. Lazera. 1998. Cryptococcus neoformans isolated from human dwellings in Rio de Janeiro, Brazil: an analysis of the domestic environment of AIDS patients with and without cryptococcosis. Med. Mycol. 36: 305– 311.

85. Paterson, D. L.,, N. Singh,, T. Gayowski, and, I. R. Marino. 1998. Pulmonary nodules in liver transplant recipients. Medicine 77: 50– 58.

86. Pfeiffer, T. J., and, D. H. Ellis. 1992. Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis. J. Med. Vet. Mycol. 30: 407– 408.

87. Randhawa, H. S., and, D. K. Paliwal. 1979. Survey of Cryptococcus neoformans in the respiratory tract of patients with bronchopulmonary disorders and in the air. Sabouraudia 17: 399– 404.

88. Rolston,, K. V.,, S. Rodriguez,, N. Dholakia,, E. Whimbey, and, I. Raad. 1997. Pulmonary infections mimicking cancer: a retrospective, three-year review. Support Care Cancer 5: 90– 93.

89. Rozenbaum, R., and, A. J. Goncalves. 1994. Clinical epidemiological study of 171 cases of cryptococcosis. Clin. Infect. Dis. 18: 369– 380.

90. Saha,, D. C.,, D. L. Goldman,, X. Shao,, A. Casadevall,, S. Husain,, A. P. Limaye,, M. Lyon,, J. Somani,, K. Pursell,, T. L. Pruett, and, N. Singh. 2007. Serologic evidence for reactivation of cryptococcosis in solidorgan transplant recipients. Clin. Vaccine Immunol. 14: 1550– 1554.

91. Salyer, W. R.,, D. C. Salyer, and, R. D. Baker. 1974. Primary complex of Cryptococcus and pulmonary lymph nodes. J. Infect. Dis. 130: 74– 77.

92. Santangelo,, R.,, H. Zoellner,, T. Sorrell,, C. Wilson,, C. Donald,, J. Djordjevic,, Y. Shounan, and, L. Wright. 2004. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect. Immun. 72: 2229– 2239.

93. Seaton,, R. A.,, A. J. Hamilton,, R. J. Hay, and, D. A. Warrell. 1996. Exposure to Cryptococcus neoformans var. gattii: a seroepidemiological study. Trans. R. Soc. Trop. Med. Hyg. 90: 508– 512.

94. Shelburne,, S. A.,, 3rd, J. Darcourt, A. C. White,, Jr., S. B. Greenberg,, R. J. Hamill,, R. L. Atmar, and, F. Visnegarwala. 2005. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 40: 1049– 1052.

95. Shrestha,, R. K.,, J. K. Stoller,, G. Honari, G. W. Procop, and, S. M. Gordon. 2004. Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel. Respir. Care 49: 606– 608.

96. Silveira,, F. P.,, S. Husain, E. J. Kwak,, P. K. Linden,, A. Marcos,, R. Shapiro,, P. Fontes,, J. W. Marsh,, M. de Vera,, K. Tom,, N. Thai,, H. P. Tan,, A. Basu,, K. Soltys, and, D. L. Paterson. 2007. Cryptococcosis in liver and kidney transplant recipients receiving antithymocyte globulin or alemtuzumab. Transpl. Infect. Dis. 9: 22– 27.

97. Sorrell, T. C. 2001. Cryptococcus neoformans var. gattii. Med. Mycol. 39: 155– 168.

98. Sorrell,, T. C.,, A. G. Brownlee,, P. Ruma,, R. Malik,, T. J. Pfeiffer, and, D. H. Ellis. 1996. Natural environmental sources of Cryptococcus neoformans var. gattii. J. Clin. Microbiol. 34: 1261– 1263.

99. Sorrell,, T. C.,, S. C. Chen,, P. Ruma,, W. Meyer,, T. J. Pfeiffer,, D. H. Ellis, and, A. G. Brownlee. 1996. Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J. Clin. Microbiol. 34: 1253– 1260.

100. Speed, B. R., and, J. Kaldor. 1997. Rarity of cryptococcal infection in children. Pediatr. Infect. Dis. J. 16: 536– 537.

101. Speed, B. R.,, J. Kaldor,, B. Cairns, and, M. Pegorer. 1996. Serum antibody response to active infection with Cryptococcus neoformans and its varieties in immunocompetent subjects. J. Med. Vet. Mycol. 34: 187– 193.

102. Stephen, C.,, S. Lester,, W. Black,, M. Fyfe, and, S. Raverty. 2002. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can. Vet. J. 43: 792– 794.

103. Sullivan,, D.,, K. Haynes,, G. Moran,, D. Shanley,, and D. Coleman. 1996. Persistence, replacement, and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients. J. Clin. Microbiol. 34: 1739– 1744.

104. Sweeney,, D. A.,, M. T. Caserta,, D. N. Korones,, A. Casadevall, and, D. L. Goldman. 2003. A ten-year-old boy with a pulmonary nodule secondary to Cryptococcus neoformans: case report and review of the literature. Pediatr. Infect. Dis. J. 22: 1089– 1093.

105. True, D. G.,, M. Penmetcha, and, S. J. Peckham. 2002. Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab. J. Rheumatol. 29: 1561– 1563.

106. USPHS/IDSA Prevention of Opportunistic Infection Working Group. 2002. Guidelines for preventing opportunistic infections among HIV-infected persons. MMWR Recomm. Rep. 51: 1– 41.

107. USPHS/IDSA Prevention of Opportunistic Infection Working Group. 1995. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with the human immunodeficiency virus: diseasespecific recommendations. Clin. Infect. Dis. 21(Suppl. 1) : S32– 43.

108. Vanbreuseghem R., and, M. Takashio. 1970. An atypical strain of Cryptococcus neoformans (San Felice) Vuillemin 1894. Part II. Cryptococcus neoformans var gattii var. nov. Belg. Med. Trop. 50: 695– 702.

109. Varma, A., and, K. J. Kwon-Chung. 1991. Rapid method to extract DNA from Cryptococcus neoformans. J. Clin. Microbiol. 29: 810– 812.

110. Varma, A.,, D. Swinne,, F. Staib,, J. E. Bennett, and, K. J. Kwon-Chung. 1995. Diversity of DNA fingerprints in Cryptococcus neoformans. J. Clin. Microbiol. 33: 1807– 1814.

111. Vicencio,, A. G.,, S. Narain,, Z. Du,, W. Y. Zeng,, J. Ritch,, A. Casadevall, and, D. L. Goldman. 2008. Pulmonary cryptococcosis induces chitinase in the rat. Respir. Res. 9: 40.

112. Walter, J. E., and, R. W. Atchison. 1966. Epidemiological and immunological studies of Cryptococcus neoformans. J. Bacteriol. 92: 82– 87.

113. Wang, C. Y.,, H. D. Wu, and, P. R. Hsueh. 2005. Nosocomial transmission of cryptococcosis. N. Engl. J. Med. 352: 1271– 1272.

114. Wilson, M. L.,, L. D. Sewell, and, C. M. Mowad. 2008. Primary cutaneous cryptococcosis during therapy with methotrexate and adalimumab. J. Drugs. Dermatol. 7: 53– 54.

115. Woods, M. L., 2nd,, R. MacGinley,, D. P. Eisen, and, A. M. Allworth. 1998. HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12: 1491– 1494.